Citadel Advisors
HSCSW icon

Citadel Advisors’s HeartSciences Inc Warrant HSCSW Stock Holding History

Citadel Advisors’s Portfolio HSCSW Stock Details HSCSW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.56K Sell
187,495
-5,092
-3% -$309 ﹤0.01% 13502
2026
Q1 		$22K Sell
192,587
-2,972
-2% -$281 ﹤0.01% 12654
2025
Q4 		$8.82K Sell
195,559
-18,539
-9% -$1.42K ﹤0.01% 12438
2025
Q3 		$29.8K Sell
214,098
-9,421
-4% -$1.01K ﹤0.01% 12397
2025
Q2 		$20.4K Sell
223,519
-1,290
-0.6% -$94 ﹤0.01% 12102
2025
Q1 		$11K Buy
224,809
+10,652
+5% +$471 ﹤0.01% 13515
2024
Q4 		$6.45K Sell
214,157
-6,271
-3% -$236 ﹤0.01% 13794
2024
Q3 		$9.68K Sell
220,428
-3,900
-2% -$165 ﹤0.01% 13242
2024
Q2 		$11K Buy
224,328
+195,750
+685% +$7.4K ﹤0.01% 13058
2024
Q1 		$1.43K Sell
28,578
-400
-1% -$26 ﹤0.01% 14132
2023
Q4 		$2.32K Buy
28,978
+813
+3% +$52 ﹤0.01% 13710
2023
Q3 		$1.41K Buy
28,165
+14,316
+103% +$1.58K ﹤0.01% 13871
2023
Q2 		$2.17K Buy
13,849
+3,639
+36% +$652 ﹤0.01% 13816
2023
Q1 		$2.3K Sell
10,210
-17,944
-64% -$4.3K ﹤0.01% 14169
2022
Q4 		$7.67K Buy
+28,154
New +$9.39K ﹤0.01% 13809

Other funds holding HSCSW

CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Citadel Advisors's HSCSW Position: Q2 2026 in Review

Citadel Advisors reduced its HeartSciences Inc Warrant (HSCSW) stake by 2.6% in Q2 2026, selling an estimated $309 and leaving 187,495 shares worth $9.56K. The position accounts for ﹤0.01% of the portfolio, ranked #13502.

Citadel Advisors first reported a position in HSCSW in Q4 2022 and has held it in 15 quarters since. The position peaked at $29.8K in Q3 2025. 3 funds tracked by Wall St. Rank hold HSCSW as of Q2 2026.

  • Citadel Advisors held 187,495 shares of HeartSciences Inc Warrant worth $9.56K as of Q2 2026.
  • Citadel Advisors sold 5,092 HeartSciences Inc Warrant shares in Q2 2026, an estimated $309.
  • HeartSciences Inc Warrant made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #13502 holding.
  • Citadel Advisors first reported a position in HeartSciences Inc Warrant in Q4 2022 and has held it in 15 quarters since.
  • Citadel Advisors's HeartSciences Inc Warrant position peaked at $29.8K in Q3 2025.
  • 3 funds tracked by Wall St. Rank held HeartSciences Inc Warrant as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.